Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK. - Wikidata - awgldk - TriplyDB

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

http://www.wikidata.org/entity/Q43120546

about

Autophagy in Chronic Kidney Diseases Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol Autophagy in kidney health and disease.Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cells Risperidone-Induced Renal Damage and Metabolic Side Effects: The Protective Effect of Resveratrol Resveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulin Autophagy in diabetic nephropathy Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.Signaling mechanisms in the regulation of renal matrix metabolism in diabetes.EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells.Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.Sugar, sex, and TGF-β in diabetic nephropathy.Resveratrol Ameliorates Diabetes-induced Renal Damage through Regulating the Expression of TGF-β1, Collagen IV and Th17/Treg-related Cytokines in Rats.Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway.Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.Autophagy as a therapeutic target in diabetic nephropathy.Pathophysiology of the aging kidney and therapeutic interventions.Sirtuins' modulation of autophagy.Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.Renal protective effects of resveratrol.Natural polyphenols based new therapeutic avenues for advanced biomedical applications.Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells.Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.Estrogen receptor subtype ratio change protects against podocyte damage.Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease.Resveratrol provides benefits in mice with type II diabetes-induced chronic renal failure through AMPK signaling pathway.

P2860

Q26740427-6AFBDF7C-8C04-4394-9D04-DE18A7F149C4 Q26771919-F4093262-8551-4C1D-97A3-44804043E5A4 Q26800907-4EB13D74-97A5-4CE1-A179-FC8125CB6D6E Q27687496-4FFA085A-011B-4744-9733-3316BAD8F680 Q28534677-3EACD327-2000-47AC-96F4-41B887DE0A35 Q33863719-7311126B-3B47-4D53-9830-1244668A1A08 Q34338591-F53030F8-E548-455C-BCD9-E84EDD101634 Q34445143-A4FCEC6A-4A33-4860-B119-D3DA2D9404A1 Q34782924-3679F407-1F64-4734-B508-5C45AE4F1BBC Q35147432-931A5D1D-86B4-4F91-9F8E-29CD041EAE04 Q35791976-32A8F8E3-3D08-4FD2-AFB9-922B155976B6 Q35833116-7D0BF54F-1922-404A-85D3-A628949D955D Q36089679-FE9A51C9-8E99-4D22-B27B-AD1CDEA4592C Q36234919-40EE1164-E7EB-4D30-92F8-0B635F4168F9 Q36306351-D2C0D902-1A19-4E51-B309-0B557A48681F Q36801780-14D747E9-0ACC-4CDA-9104-96583A7FAB67 Q37142481-6AED8853-08E2-4DC6-902F-DBACD8ECFC21 Q37615803-E4EBC441-6BF4-42E8-BD23-66B39A101D75 Q37736609-48467E81-6C6F-4240-A2C7-88627DBB8560 Q37949588-A4C9E835-5B82-403A-8A06-6BF28966EC61 Q38053074-E0ECD33E-2A20-4B0A-BC0F-186530BCDD96 Q38108575-E1EB7181-F115-4FA5-95C6-15AF0C853B6B Q38162106-CEA16F1F-F1FF-4680-A4FE-016AE25B86E3 Q38174888-FF07AF2B-10AE-481B-8862-E6353B6DCE8C Q38622865-F28EAFD0-0ABB-4EB6-AE2F-65D1ACB79295 Q39321120-A87392B6-806D-405B-A516-F75B7533065C Q42747749-F5306444-89BB-4521-A9ED-F73E7FDEBDEA Q46131293-476DF85A-4856-4A50-B540-1AE873A66299 Q46312225-216D2C72-79A3-4C0E-8621-E37EEB6D12C6 Q47549327-83BB5266-6F32-4631-B69B-07EB13329074 Q48666820-1BD01904-3082-4271-93B6-C9AA643A7E4C Q55286919-5CD7BF1A-C413-497C-84CA-92E7FF519CE1

P2860

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

http://www.wikidata.org/entity/Q43120546

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

@en

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

@nl

type

label

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

@en

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

@nl

prefLabel

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

@en

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

@nl

P1433

Q43120546-635F96A1-C148-4E1C-906D-E13B56BA7EEA

P1476

Q43120546-9DBA8AFF-322D-4123-BD8F-659117CD0622

P2093

Q43120546-0C3B5C40-3571-4104-9FCB-E05F4585647E

Q43120546-0FCBF23B-AD43-415A-8387-299332C552BE

Q43120546-18B1A49A-0AA6-4841-BAEA-9B76408C7121

Q43120546-29DD6011-0AAB-44C5-9FC9-EFB8DC314314

Q43120546-56FE0391-0A96-4452-B764-B7E860233CA0

Q43120546-69AA25D8-DE9D-4324-A5F3-C7D574F21752

Q43120546-79D77E79-D0D0-42EA-94E3-419CAB0FB204

Q43120546-8E33BAF5-8540-4DEA-802B-BA06D431F03F

Q43120546-941E57DD-647C-466A-B6B2-5C7EB4D8E493

Q43120546-D752D76B-859C-405E-8BE5-A8E7263A23B1

P304

Q43120546-D22ED409-768B-4011-ACEC-113E480B6F0C

P31

Q43120546-E02681AD-8A61-4F60-B23C-2D05B746754D

P356

Q43120546-83FD1471-CD92-424C-9C91-8022111A3671

P433

Q43120546-BDD9A8C7-4627-4A17-A46A-9AB1E147AC3F

P478

Q43120546-8C3F7B5D-F7E3-4FC4-B33C-F32C12ED12D6

P50

Q43120546-44E4072D-8207-4BDB-82A3-7FE0C7E02C4B

P577

Q43120546-210CFF52-2756-4BA0-AEF5-2AF95FFAE2C1

P698

Q43120546-2D22C242-20B7-40BC-B60E-9CC38002059A

P356

P1433

American Journal of Nephrology

P1476

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK

@en

P2093

Ai-Ping Hu

http://www.w3.org/2001/XMLSchema#string

Chao Liu

http://www.w3.org/2001/XMLSchema#string

Da-Fa Ding

http://www.w3.org/2001/XMLSchema#string

Heng Miao

http://www.w3.org/2001/XMLSchema#string

Jia-Rong Xu

http://www.w3.org/2001/XMLSchema#string

Na You

http://www.w3.org/2001/XMLSchema#string

Qun Zhu

http://www.w3.org/2001/XMLSchema#string

Xiao-Long Ye

http://www.w3.org/2001/XMLSchema#string

Xiao-Mei Wu

http://www.w3.org/2001/XMLSchema#string

Xiu-Qing Jiang

http://www.w3.org/2001/XMLSchema#string

P304

363-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000300388

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20332614

http://www.w3.org/2001/XMLSchema#string